Abstract
Rezvilutamide in combination with androgen-deprivation therapy, with or without salvage radiotherapy, for patients experiencing biochemical recurrence following radical prostatectomy: A multi-center, open-label, two-cohort study.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have